Estados financieros detallados de Grace Therapeutics, Inc. (GRCE): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $2.14, GRCE presenta beneficios negativos (P/E no significativo) y un ROE del -35.78%. La capitalización bursátil es de $35M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | $309318 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $2.6M | $2.7M | $3.1M | 0 | $119938 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$2.6M | -$2.7M | -$3.1M | 0 | $189378 | 0 | 0 | 0 | 0 | 0 |
| I+D | $7.2M | $12.1M | $29.4M | $31.9M | $6.6M | $6.9M | $13.5M | $6.4M | $13.5M | $2.4M |
| Generales y Administrativos | $768742 | $3.1M | $4.3M | $16.9M | $10.5M | $12.2M | $11.1M | $9.0M | $10.2M | $8.7M |
| Gastos Operativos | $8.0M | $15.3M | $42.5M | $48.8M | $26.1M | $19.5M | $70.5M | $17.4M | $23.8M | $11.1M |
| Beneficio Operativo | -$10.5M | -$15.3M | -$34.4M | -$48.8M | -$25.9M | -$19.5M | -$70.5M | -$17.4M | -$23.8M | -$11.1M |
| EBITDA | -$8.0M | -$14.3M | -$36.8M | -$45.9M | -$15.5M | -$19.2M | -$24.5M | -$15.4M | -$23.7M | -$11.1M |
| Gastos por Intereses | $54439 | $371622 | $1.1M | $414177 | $331649 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$10.7M | -$16.7M | -$39.4M | -$51.0M | -$31.1M | -$13.1M | -$70.3M | -$19.9M | -$18.2M | -$9.5M |
| Impuestos | -$121083 | 0 | 0 | 0 | 0 | -$809658 | -$12.9M | -$2.5M | -$4.6M | -$1.7M |
| Beneficio Neto | -$10.6M | -$16.7M | -$39.4M | -$51.0M | -$31.1M | -$12.3M | -$57.4M | -$17.4M | -$13.6M | -$7.8M |
| BPA | $-45.67 | $-59.30 | $-46.58 | $-28.78 | $-12.59 | $-2.02 | $-7.72 | $-1.83 | $-1.13 | $-0.47 |
| BPA Diluido | $-45.67 | $-59.30 | $-46.58 | $-28.78 | $-12.59 | $-2.02 | $-7.72 | $-1.83 | $-1.13 | $-0.47 |
| Acciones en Circulación (Diluidas) | $231135 | $364302 | $1.1M | $1.8M | $2.5M | $6.1M | $7.4M | $9.5M | $12.1M | $16.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$2000 | 0 |
| Beneficio Operativo | -$3.5M | -$3.4M | -$3.0M | -$15.8M |
| EBITDA | -$3.5M | -$3.4M | -$3.0M | -$15.8M |
| Beneficio Neto | -$1.3M | -$3.2M | -$1.2M | -$15.8M |
| BPA | $-0.08 | $-0.19 | $-0.07 | $-0.91 |
| BPA Diluido | $-0.08 | $-0.19 | $-0.07 | $-0.91 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Caja y Equivalentes | 0 | $6.4M | $16.9M | $20.1M | $64.0M | $30.3M | $27.9M | $23.0M | $22.1M | $17.0M |
| Inversiones a Corto | 0 | 0 | $8.9M | 0 | $12.3M | $13.3M | $15000 | 0 | 0 | 0 |
| Cuentas por Cobrar | $206167 | $759260 | $1.6M | $771811 | $665810 | $548000 | $802000 | $722000 | $126000 | $20000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $10.2M | $7.4M | $28.0M | $22.6M | $78.4M | $45.5M | $29.3M | $24.0M | $22.7M | $17.4M |
| Inmovilizado Material | $2.9M | $2.2M | $2.1M | $2.9M | $108037 | $315000 | $567000 | $24000 | $15000 | $8000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | $13.0M | $8.1M | $8.1M | $8.1M | $8.1M |
| Activos Intangibles | $12.4M | $7.8M | $6.4M | $6.0M | 0 | $69.8M | $41.1M | $41.1M | $41.1M | $41.1M |
| Activos Totales | $25.5M | $17.8M | $36.9M | $32.3M | $78.5M | $128.6M | $79.1M | $73.3M | $72.0M | $66.7M |
| Cuentas por Pagar | 0 | $2.6M | $3.0M | $2.4M | $144468 | $3.2M | $1.2M | $1.0M | $601000 | $702000 |
| Deuda a Corto | 0 | 0 | $1.4M | $121567 | $108037 | $104000 | $75000 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.1M | $5.2M | $13.7M | $10.5M | $2.0M | $3.3M | $3.4M | $1.7M | $1.9M | $2.1M |
| Deuda a Largo | $1.4M | $1.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $3.8M | $11.4M | $25.9M | $13.9M | $8.5M | $20.4M | $11.2M | $11.6M | $5.4M | $2.8M |
| Reservas | -$50.9M | -$56.0M | -$100.8M | -$178.6M | -$183.4M | -$155.8M | -$198.3M | -$211.1M | -$220.7M | -$228.5M |
| Patrimonio Neto | $21.7M | $6.4M | $11.0M | $18.4M | $69.9M | $108.3M | $68.0M | $61.7M | $66.6M | $63.9M |
| Deuda Total | $1.4M | $1.2M | $1.4M | $207795 | $108037 | $295000 | $485000 | 0 | 0 | 0 |
| Deuda Neta | -$8.4M | -$5.1M | -$24.4M | -$19.9M | -$76.2M | -$43.4M | -$27.4M | -$23.0M | -$22.1M | -$17.0M |
| Capital Circulante | $8.1M | $2.2M | $14.3M | $12.1M | $76.4M | $42.3M | $25.9M | $22.3M | $20.8M | $15.2M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $16.9M | $18.7M | $17.0M | $13.8M |
| Activos Totales | $66.6M | $68.5M | $66.7M | $50.1M |
| Pasivos Totales | $3.8M | $3.6M | $2.8M | $1.9M |
| Patrimonio Neto | $62.8M | $64.9M | $63.9M | $48.2M |
| Deuda Total | 0 | 0 | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Beneficio Neto | -$10.6M | -$16.7M | -$39.4M | -$36.1M | -$24.7M | -$9.8M | -$42.4M | -$12.9M | -$9.6M | -$7.8M |
| Amortizaciones | $2.6M | $2.1M | $2.3M | $3.3M | $1.2M | 0 | $124000 | $11000 | $7000 | $7000 |
| Compensación en Acciones | 0 | $719368 | $777000 | $2.8M | $1.5M | $1.3M | $1.8M | $913000 | $730000 | $798000 |
| Cambio en Capital Circulante | $805356 | $2.8M | $6.2M | -$4.5M | -$7.5M | -$2.8M | $181000 | -$1.3M | $342000 | $719000 |
| Flujo de Caja Operativo | -$6.9M | -$9.7M | -$24.8M | -$32.4M | -$18.0M | -$17.2M | -$15.9M | -$12.3M | -$14.9M | -$8.9M |
| Inversiones (CapEx) | -$2.6M | -$352328 | -$534000 | -$450930 | -$86681 | 0 | -$17000 | -$22000 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | -$30973 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$9.5M | -$10.0M | -$25.3M | -$32.9M | -$18.1M | -$17.2M | -$15.9M | -$12.4M | -$14.9M | -$8.9M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$3.2M | -$2.2M | -$1.7M | -$3.2M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.2M | -$2.2M | -$1.7M | -$3.2M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | $314000 | -$24000 | $105000 |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Crecimiento Ingresos (anual) | | | | | | -100.0% | | | | |
| Crecimiento Beneficio Neto (anual) | | -57.7% | -136.4% | -29.5% | +39.1% | +60.5% | -367.8% | +69.6% | +21.9% | +42.8% |
| Crecimiento BPA (anual) | | -29.8% | +21.5% | +38.2% | +56.3% | +84.0% | -282.2% | +76.3% | +38.3% | +58.4% |
| Cambio en Acciones (anual) | | +57.6% | +210.5% | +55.8% | +40.2% | +148.5% | +21.1% | +28.2% | +26.8% | +36.6% |
| Crecimiento FCF (anual) | | -5.6% | -152.0% | -29.9% | +45.1% | +4.7% | +7.6% | +22.4% | -20.6% | +40.5% |
| Margen Bruto | | | | | 61.2% | | | | | |
| Margen Operativo | | | | | -8377.1% | | | | | |
| Margen EBITDA | | | | | -4995.9% | | | | | |
| Margen Neto | | | | | -10039.8% | | | | | |
| Margen FCF | | | | | -5843.5% | | | | | |
| Tasa Impositiva Efectiva | 1.1% | -0.0% | -0.0% | -0.0% | -0.0% | 6.2% | 18.4% | 12.5% | 25.1% | 17.9% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| FCF por Acción | $-41.15 | $-27.58 | $-22.39 | $-18.67 | $-7.31 | $-2.81 | $-2.14 | $-1.30 | $-1.23 | $-0.54 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $231135 | $364302 | $1.1M | $1.8M | $2.5M | $6.1M | $7.4M | $9.5M | $12.1M | $16.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -35.78% |
| Rentabilidad sobre capital invertido | -48.75% |
| Rentabilidad sobre activos | -42.84% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 11.47 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 11.56 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| P/E | -0.09 | -0.07 | -0.09 | -0.15 | -0.30 | -1.49 | -0.39 | -1.64 | -2.02 | -9.85 |
| P/VC | 0.04 | 0.22 | 0.41 | 0.41 | 0.13 | 0.17 | 0.33 | 0.46 | 0.41 | 1.20 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 30.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 61.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | -8377.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | -10039.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |